Global Rare Disease Diagnostics Market Insights 2024-2030: Rising Use in Translational & Genomic Research Driving the Industry to $8.23 Billion by 2030
08 mai 2024 05h07 HE
|
Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Global Rare Disease Diagnostics Market by Component (Consumable & Assay Kit, Diagnostic Instrument), Technology (Array Technology, Next Generation...
Diagnostic Collaboration, Development, Research and Licensing Deals Analysis Report 2024 with Directory of 1640 Agreements Signed Since 2019
07 mai 2024 06h26 HE
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Diagnostic Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering.Diagnostic Collaboration and...
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region
06 mai 2024 01h00 HE
|
Biocartis NV
PRESS RELEASE - 06/05/2024, 07:00 CEST Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region Biocartis (Mechelen,...
Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
30 avr. 2024 16h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient...
Using AI to Improve Diagnosis of Rare Genetic Disorders
25 avr. 2024 09h19 HE
|
Baylor Genetics
Diagnosing rare Mendelian disorders is a labor-intensive task, even for experienced geneticists. Investigators at Baylor College of Medicine are trying to
Promising perspectives for the application of SDS Optic’s inPROBE technology platform for protein expression determination
25 avr. 2024 08h00 HE
|
SDS Optic S.A.
SDS Optic's positive results from the Part I Clinical Trial of the novel optic fiber probe, inPROBE®, in vivo real-time molecular diagnostic technology.
deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024
25 avr. 2024 03h00 HE
|
DeepUll
deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024 UllCORE is designed to transform life-saving clinical decision making for sepsis...
Global Market for Exosome Diagnostics, Therapeutics, and Research Tools (2021-2028) Featuring Bio-Techne, Exosomics, and System Biosciences - An Evaluation of New Commercial Opportunities and Emerging Trends
24 avr. 2024 04h20 HE
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Exosome Diagnostics, Therapeutics and Research Tools: Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market...
Global Sleep Tech Device Market Trends, Forecast and Competitive Analysis, 2018-2023 and 2024-2030
19 avr. 2024 09h31 HE
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Sleep Tech Device Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The...
Global Cancer Diagnostics Market Set to Reach US$ 280.37 Billion by 2030 with Illumina, Abbott Laboratories, Thermo Fisher Scientific, QIAGEN, Roche, Pfizer, Koninklijke Philips,& bioMérieux Leading
19 avr. 2024 05h17 HE
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Cancer Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis" report...